Your session is about to expire
← Back to Search
Resistance Training for High Blood Pressure Control in Sarcopenia (INERTIA Trial)
INERTIA Trial Summary
This trial will study the effects of an exercise intervention on blood pressure in older adults with sarcopenia, in order to better understand how muscle strength affects blood pressure and identify potential targets for non-pharmacological treatments for high blood pressure.
INERTIA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.INERTIA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had cancer, except for non-melanoma skin cancer, and have been treated with radiation or chemotherapy in the past 5 years.You have a bone or joint problem that makes it unsafe to exercise.You can't walk a quarter mile or 400 meters in less than 15 minutes without stopping.You have a history of heart or blood vessel problems like heart attack, stroke, or other serious heart conditions.Lives in the Chicagoland area.You have severe osteoporosis or bone deformities that could make it unsafe for you to do strength training exercises.You live with someone who is already taking part in the study.You are currently drinking a lot of alcohol or using illegal drugs, or you have a history of alcohol or drug problems.Adults who are 60 years old or older, no matter what race they are.You have been diagnosed with dementia, Alzheimer's disease, bipolar disorder, or psychotic disorder, or have been hospitalized for psychological or emotional issues in the past 2 years.You have a medical condition like lupus, multiple sclerosis, or severe rheumatoid arthritis that would make it unsafe for you to exercise.You have good thinking and memory skills, as measured by a test called the MoCA, and you score higher than 22.Adults who don't exercise regularly or don't do strength training.You can walk or exercise without needing a device to help you.
- Group 1: Assessment-only control
- Group 2: Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could individuals still apply for enrollment in this research project?
"This investigation, which was initially posted on January 27th 2020, is actively seeking participants according to clinicaltrials.gov. The latest update occurred on June 6th 2022."
What is the total cohort size of this clinical trial?
"Correct. As per clinicaltrials.gov, this study is actively seeking participants from a single location and aims to recruit 90 patients in total. It was initially posted on January 27th 2020, with the most recent update being made June 6th 2022."
Share this study with friends
Copy Link
Messenger